8,388
Deferred revenue-noncurrent 47,332 76,235
Total liabilities 170,129 206,666
Stockholders' equity
Preferred stock, $0.001 par value;
authorized: 5,000,000 shares at
December 29, 2007 and June 30,
2007; no shares issued and
outstanding. - -
Common stock, $0.001 par value;
authorized: 100,000,000 shares at
December 29, 2007 and June 30, 2007;
issued and outstanding: 55,267,398 and
55,045,347 shares, respectively, at
December 29, 2007 and 53,798,643 and
53,798,643 shares, respectively, at
June 30, 2007. 55 53
Additional paid-in capital 262,240 251,637
Accumulated other comprehensive
income (loss) (31) 10
Accumulated deficit (121,901) (126,257)
Total stockholders' equity 140,363 125,443
Total liabilities and stockholders'
equity $310,492 $332,109
'/>"/>SOURCE Accuray Incorporated Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 Related medicine news :1.
Accuray Incorporated to Report Second Quarter Fiscal Year 2008 Financial Results2.
Accuray Exceeds 4,000 Lung Cancer Patients Treated with CyberKnife(R) System3.
Accuray Reports Record Revenue in First Quarter of Fiscal 20084.
Accuray Announces Four New Products at Nations Leading Radiation Oncology Meeting5.
Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO 20076.
Accuray Incorporated to Report First Quarter Fiscal Year 2008 Financial Results7.
Accuray to Webcast Senior Management Presentations at Analyst Day Event8.
Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference9.
Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery10.
Cardinal Health Reports Second Quarter Results, Revises EPS Outlook11.
Encision Reports Third Fiscal Quarter Results